Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Mulder

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Thrombosis Research|November 17, 2019
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer studyF I Mulder, N van Es, N Kraaijpoel, et al.
Thrombosis Research|March 11, 2020
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19]F I Mulder, N van Es, N Kraaijpoel, et al.
Emergency Medicine Journal : EMJ|November 7, 2022
Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS StudyRoisin Bavalia, Milou A M Stals, Frits I Mulder, et al.
Thrombosis and Haemostasis|July 31, 2018
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer StudyNoémie Kraaijpoel, Marcello Di Nisio, Frits I Mulder, et al.
Thrombosis Research|November 2, 2023
RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control studyMaaike Y Kapteijn, Vincent R Lanting, Fleur H J Kaptein, et al.
Journal of Thrombosis and Haemostasis : JTH|August 19, 2021
Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancerNoori A M Guman, Roos J van Geffen, Frits I Mulder, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2024
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE studyNoori A M Guman, Anne-Marie L Becking, Suzanne S Weijers, et al.
Journal of Thrombosis and Haemostasis : JTH|February 25, 2023
Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort studyFrits I Mulder, Noémie Kraaijpoel, Marc Carrier, et al.
Research and Practice in Thrombosis and Haemostasis|October 1, 2025
Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE studyNoori A M Guman, Noémie Kraaijpoel, Frits I Mulder, et al.
Circulation. Genomic and Precision Medicine|April 10, 2026
Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid CancerFrits I Mulder, Noori A M Guman, Job van Riet, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Thrombosis Research|November 17, 2019
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer studyF I Mulder, N van Es, N Kraaijpoel, et al.
Thrombosis Research|March 11, 2020
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19]F I Mulder, N van Es, N Kraaijpoel, et al.
Emergency Medicine Journal : EMJ|November 7, 2022
Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS StudyRoisin Bavalia, Milou A M Stals, Frits I Mulder, et al.
Thrombosis and Haemostasis|July 31, 2018
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer StudyNoémie Kraaijpoel, Marcello Di Nisio, Frits I Mulder, et al.
Thrombosis Research|November 2, 2023
RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control studyMaaike Y Kapteijn, Vincent R Lanting, Fleur H J Kaptein, et al.
Journal of Thrombosis and Haemostasis : JTH|August 19, 2021
Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancerNoori A M Guman, Roos J van Geffen, Frits I Mulder, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2024
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE studyNoori A M Guman, Anne-Marie L Becking, Suzanne S Weijers, et al.
Journal of Thrombosis and Haemostasis : JTH|February 25, 2023
Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort studyFrits I Mulder, Noémie Kraaijpoel, Marc Carrier, et al.
Research and Practice in Thrombosis and Haemostasis|October 1, 2025
Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE studyNoori A M Guman, Noémie Kraaijpoel, Frits I Mulder, et al.
Circulation. Genomic and Precision Medicine|April 10, 2026
Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid CancerFrits I Mulder, Noori A M Guman, Job van Riet, et al.
Pageof 6